Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)

Kensei Yamaguchi, Akira Sawaki, Toshihiko Doi, Taroh Satoh, Yasuhide Yamada, Yasushi Omuro, Tomohiro Nishina, Narikazu Boku, Keisho Chin, Yasuo Hamamoto, Hiroya Takiuchi, Yoshito Komatsu, Shigehira Saji, Wasaburo Koizumi, Yoshinori Miyata, Atsushi Sato, Eishi Baba, Takao Tamura, Takashi Abe, Atsushi Ohtsu

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)183-184
Number of pages2
JournalGastric Cancer
Volume16
Issue number2
DOIs
Publication statusPublished - 2013 Apr

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Cancer Research

Cite this

Yamaguchi, K., Sawaki, A., Doi, T., Satoh, T., Yamada, Y., Omuro, Y., Nishina, T., Boku, N., Chin, K., Hamamoto, Y., Takiuchi, H., Komatsu, Y., Saji, S., Koizumi, W., Miyata, Y., Sato, A., Baba, E., Tamura, T., Abe, T., & Ohtsu, A. (2013). Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0). Gastric Cancer, 16(2), 183-184. https://doi.org/10.1007/s10120-012-0205-y